Malignant fibrous histiocytoma of the pancreas: A case report with genetic analysis

Cancer

Volumn 85, Issue 11, 1999, Pages 2352-2358

  Bastian, Daniel ^a   Ramaswamy, Annette ^a   Barth, Peter J ^a   Gerdes, Berthold ^a   Ernst, Michael ^a   Bartsch, Detlef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

DPC4; K ras; Malignant fibrous histiocytoma; p16; p53; Pancreas; Surgery

Indexed keywords

PROTEIN P16; PROTEIN P53;

AGED; ARTICLE; CANCER SURGERY; CASE REPORT; DNA SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; ONCOGENE K RAS; PANCREAS CANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AGED; GENOTYPE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PANCREATIC NEOPLASMS;

EID: 0033151785     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990601)85:11<2352::AID-CNCR9>3.0.CO;2-7     Document Type: Article

References (49)

1. Enjoji M, Hashimoto H. Diagnosis of soft tissue sarcomas. Pathol Res Pract 1984;178:215-26.
2. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978;41:2250-66.
3. Yousem SA, Hochholzer L. Malignant fibrous histiocytoma of the lung. Cancer 1987;60:2532-41.
4. Usher SM, Beckley S, Merrin C. Malignant fibrous histiocytoma of the retroperitoneum and genitourinary tract: a clinicopathological correlation and a review of the literature. J Urol 1979;122:105-9.
5. Wright JR, Kyriakos M, DeSchryver-Kecskemeti K. Malignant fibrous histiocytoma of the stomach. A report and review of malignant fibrohistiocytic tumors of the alimentary tract. Arch Pathol Lab Med 1988;112:251-8.
6. Fukayama M, Koike M. Malignant fibrous histiocytoma arising in the liver. Arch Pathol Lab Med 1986;110:203-6.
7. Laya MB, Mailliard JA, Bewtra C, Levin HS. Malignant fibrous histiocytoma of the heart. A case report and review of the literature. Cancer 1987;59:1026-31.
8. Margules RM, Allen RE, Dunphy JE. Pancreatic tumor of mesenchymal origin presenting as obstructive jaundice. Am J Surg 1976;131:357-9.
9. Ishiguchi T, Shimamoto K, Kaii O, Sakai M, Ishigaki T, Sakuma S, et al. Malignant fibrous histiocytoma of the pancreas. Rinsho Hoshasen 1986;31:655-8.
10. Hasegawa H, Nimura Y, Hayakawa N. A resected case of giant malignant fibrous histiocytoma of the pancreas. Jpn J Dig Surg 1987;20:106-9.
11. Garvey JF, Ng A, England JF, Sheldon DM. Malignant fibrous histiocytoma of the pancreas. HPB Surg 1989;1:233-7.
12. Pascal RR, Sullivan L, Hauser L, Ferzli G. Primary malignant fibrous histiocytoma of the pancreas. Hum Pathol 1989;20: 1215-7.
13. Suster S, Philipps M, Robinson MJ. Malignant fibrous histiocytoma (giant cell type) of the pancreas. Cancer 1989;64: 2303-8.
14. Allen KB, Skandalakis LJ, Brown BC, Gray SW, Skandalakis JE. Malignant fibrous histiocytoma of the pancreas. Am Surg 1990;56:364-8.
15. Filippini A, Lucci S, Berni A, Maggi S, Romani AM, Grilli P, et al. Malignant fibrous histiocytoma of the pancreas. G Chir 1992;13:485-8.
16. Tsujimura T, Kawano K, Taniguchi M, Yoshikawa K, Tsukaguchi I. Malignant fibrous histiocytoma coexistent with mucinous cystadenoma of the pancreas. Cancer 1992;70: 2792-6.
17. Ben Jilani S, el Mezni F, Dziri C, Khatteche A, Zermani R, Najeh N. Primary malignant histiocytofibroma of the pancreas. Apropos of a case. Arch Anat Cytol Pathol 1993;41: 167-70.
18. Balen EM, De Villa VH, Cienfuegos JA, Contreras F, Pardo F, Gonzalez J, et al. Malignant fibrous histiocytoma of the pancreas. Rev Esp Enferm Dig 1993;83:475-80.
19. Haba R, Kobayashi S, Hirakawa E, Miki H, Okino T, Kurokawa T, et al. Malignant fibrous histiocytoma of the pancreas. Pathol Int 1996;46:515-9.
20. Taubert H, Meye A, Wurl P. Prognosis is correlated with p53 mutation type for soft tissue sarcoma patients. Cancer Res 1996;56:4134-6.
21. Yoo J, Lee H, Kang C, Park W, Lee JY, Shim S. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Arch Pathol Lab Med 1997;121:395-9.
22. Dahia PLM, Aguiar RCT, Tsanaclis AM, Bendit I, Bydlowski SP, Abelin NMA, et al. Molecular and immunohistochemical analysis of p53 in phaeochromocytoma. Br J Cancer 1995; 72:1211-3.
23. Bohle RM, Brettreich S, Repp R, Borkhardt A, Kosmehl H, Altmannsberger HM. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas. Am J Pathol 1996;148:731-8.
24. Wilke W, Maillet M, Robinson R. H-ras-1 point mutations in soft tissue sarcomas. Mod Pathol 1993;6:129-32.
25. Schneider-Stock R, Radig K, Roessner A. Loss of heterozygosity on chromosome 9q21 (p16 gene) uncommon in soft-tissue sarcomas. Mol Carcinogen 1997;18:63-5.
26. Neumann K, Ramaswamy A, Schmitz-Moormann P. Immunohistochemistry of soft tissue tumors. Tumordiogn Ther 1990;11:120-4.
27. Van Unnik JAM, Coindre JM, Contesso G, Albus-Lutter CE, Schoidt T, Garcia-Miralles T, et al. Grading of soft tissue sarcomas: experience of the EORTC soft tissue and bone sarcoma treatment. In: Ryan JR, Baber LO, editors. Dordrecht: Kluwer Academic Publishers, 1988:7-13.
28. Geradts J, Kratzke RA, Niehans GA, Lincoln CE. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 1995;55:6006-11.
29. Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA Jr., Goodfellow PJ. Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosom Cancer 1995;14:189-95.
30. Herfarth KK, Wick MR, Marshall HN, Gartner E, Lum S, Moley JF. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas. Genes Chromosom Cancer 1997;20:24-9.
31. Hahn SA, Bartsch D, Schroers A, Becker M, Ramaswamy A, Maschek H, et al. Mutations of the DPC4/Smad4 gene in bilary tract carcinoma. Cancer Res 1998;58:1124-6.
32. Urban T, Ricci S, Grange JD, Lacave R, Boudghene F, Breittmayer F, et al. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst 1993;85:2008-12.
33. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987;2:961-3.
34. Cubilla AL, Fitzgerald PJ. Tumors of the exocrine pancreas. In: Atlas of tumor pathology, fascicle 19. Washington, DC: Armed Forces Institute of Pathology, 1984.
35. Stout AP, Lattes R. Tumors of the soft tissue. In: Atlas of tumor pathology, 2nd series. fascicle 1. Washington DC: Armed Forces Institute of Pathology, 1967.
36. Meister P. Malignant fibrous histiocytoma. History, histology, histogenesis. Pathol Res Pract 1988;183:1-7.
37. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, et al. Molecular abnormalities of mdm2 and p53 in adult soft tissue sarcomas. Cancer Res 1994;54:794-9.
38. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, et al. Nuclear immunoreactions of p53 in soft tissue sarcomas. Br J Cancer 1993;68:1134-9.
39. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994;8:27-32.
40. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 1997;57:3126-30.
41. Howe JR, Roth S, Ringold JC, Summers RW, Jarvinen HJ, Sistonen P, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
42. Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996;271:350-3.
43. Caldas C, Kern SE. K-ras mutation and pancreatic carcinoma. Int J Pancreatol 1995;18:1-6.
44. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Kloppel G, et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991;64: 1076-82.
45. Bartsch D, Hahn SA, Danichevski KD, Ramaswamy A, Bastian D, Galehdari H, et al. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene. In press.
46. Bartsch D, Bastian D, Barth P, Schudy A, Nies C, Kisker O, et al. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann Surg 1998;228:79-86.
47. Kearney MM, Soule EH, Ivins JC. Malignant fibrous histiocytoma: a retrospective study of 167 cases. Cancer 1980;45: 167-78.
48. Hahn SA, Kern SE, Schmiegel WH. Neue molekularbiologische Erkenntnisse aus der Pankreaskarzinom-Forschung. Dt Ärztebl 1997;94:3342-50.
49. Bartsch D, Shevlin DW, Callery MP, Norton JA, Wells SA, Goodfellow PJ. Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 Mutation. J Natl Cancer Inst 1996;88:680-2.